Positron Emission Tomography

Cerveau tapped for Alzheimer's research

Cerveau tapped for Alzheimer's research

By Melissa Fassbender

Cerveau has signed a research agreement through which it will supply its early-stage imaging agent to assess the stages of Alzheimer’s disease and other neurodegenerative diseases.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All